Gedeon Richter’s osteoporosis biosimilar will be available on NHS
Gedeon Richter has announced that their biosimilar for osteoporosis, Teriparatide, is to be made available on the NHS for the treatment of osteoporosis in postmenopausal women and in men at increased risk of fracture. As a result, the NHS can now provide an additional option for the treatment of osteoporosis in this subset of patients.